SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-029714
Filing Date
2020-03-05
Accepted
2020-03-05 16:13:04
Documents
3
Period of Report
2020-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2011855-1_8k.htm 8-K 22075
2 EXHIBIT 99.1 tm2011855-1_ex991.htm EX-99.1 82317
3 GRAPHIC image_001.jpg GRAPHIC 5257
  Complete submission text file 0001104659-20-029714.txt   113184
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 20690953
SIC: 8731 Services-Commercial Physical & Biological Research